ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld


GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market


Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today's Transactions:
Nuron Biotech Acquires Vaccine from Pfizer

The vaccine prevents meningitis, sepsis and pneumonia

Nuron Biotech Inc. has acquired Meningitec, a meningitis vaccine, from Pfizer Inc. (NYSE: PFE) for an undisclosed amount.

The vaccine prevents diseases, such as meningitis, sepsis and pneumonia, caused by Neisseria meningitides. It is available in 23 countries, including France, Germany and Australia.

Nuron Biotech, based in Exton, Pa., develops vaccines to prevent neurodegenerative and infectious diseases.

Pfizer, based in New York, is a pharmaceutical company. In November, it closed on a purchase of NextWave Pharmaceuticals Inc., and in April, it sold off its infant-nutrition business to Nestle SA for $11.85 billion.


For more information on related topics, visit the following: